Stay updated on Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated on the page to v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe banner notice about a lapse in government funding and potential service disruption was removed. The prior notice directed users to cc.nih.gov for clinic status and opm.gov for updates.SummaryDifference0.4%

- Check34 days agoChange DetectedNo substantial changes detected in the Study Details page; core content such as inclusion/exclusion criteria, intervention, outcomes, and locations remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.SummaryDifference3%

- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.